Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment

Area of Science:

• Molecular biology
• Genetics
• Toxicology
• Carcinogenesis research

Background:

• Genetic engineering enables the creation of specialized mouse models.
• These models provide insights into the molecular mechanisms of tumor formation.
• Transgenic and knockout mice are being explored for chemical carcinogenicity testing.

Purpose of the Study:

• To review information on using genetically engineered mice for chemical carcinogenicity testing.
• To evaluate the suitability of specific mouse models (Tg.AC, rasH2, p53+/-, XPA-/-).
• To discuss the implications of findings for human health risk assessment.

Main Methods:

• Review of existing literature and data on transgenic and knockout mouse models.
• Identification of key considerations for study design, data analysis, and interpretation.
• Evaluation of mechanistic relevance for predicting human response to chemical exposure.

Main Results:

• Specific transgenic and knockout mouse lines (Tg.AC, rasH2, p53+/-, XPA-/-) are proposed for carcinogenicity testing.
• Careful consideration of animal line, study design, and data interpretation is crucial.
• Findings in these models have implications for human health risk assessment.

Conclusions:

• Genetically engineered mice can advance the understanding of carcinogenesis.
• These models may serve as adjuncts or alternatives to conventional rodent bioassays.
• Further evaluation is needed to integrate findings into human health risk assessment frameworks.